• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

有植入式心脏复律除颤器(ICD)植入指征的心力衰竭患者发生心房颤动的预测因素

Predictors of Atrial Fibrillation in Heart Failure Patients with Indications for ICD Implantation.

作者信息

Atabekov Tariel, Batalov Roman, Archakov Evgenii, Silivanova Irina, Khlynin Mikhail, Kisteneva Irina, Krivolapov Sergey, Popov Sergey

机构信息

Cardiology Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences, Kievskaya Street, 111a, Tomsk 634012, Russia.

出版信息

J Clin Med. 2025 Jun 18;14(12):4358. doi: 10.3390/jcm14124358.

DOI:10.3390/jcm14124358
PMID:40566103
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12194515/
Abstract

: Atrial fibrillation (AF) is a prevalent arrhythmia that significantly complicates the management of heart failure (HF) patients, particularly those who have implantable cardioverter-defibrillators (ICDs). The interplay between AF and inappropriate ICD therapy poses a critical challenge in optimizing patient outcomes, as inappropriate shocks can lead to increased morbidity, psychological distress, and a reduced quality of life. We aimed to explore the various clinical and demographic predictors of AF in HF patients with indications for ICD implantation. : This study included 122 patients who were indicated for ICD implantation and had undergone transthoracic echocardiography (TE). We evaluated the relationships between clinical and demographic factors and the occurrence of AF, which was recorded either before ICD implantation or during the follow-up period afterward. From our findings, we established predictors and a risk model for AF. : Out of 122 HF patients with ICDs, 52 (42.6%) experienced an episode of AF either prior to ICD implantation or during a follow-up period of 20.5 [6.0; 53.0] months, as recorded by the ICDs' endogram. Patients with AF were older compared to those without AF ( < 0.001). Additionally, they exhibited a higher left ventricular early diastolic filling rate (LVE) ( = 0.006) and a greater left atrial index (LAI) ( = 0.002). These three factors-age, LVE and LAI-were found to be independently associated with AF in both univariable and multivariable logistic regression analyses. The final model, including age, LVE, and LAI, showed a good discrimination capability with an AUC of 0.775. At a cutoff value of >0.47, the model achieved a sensitivity of 67.3% and a specificity of 77.2% in identifying HF patients with ICDs at risk for AF. : This study found that 42.6% of HF patients with ICDs experienced AF, with older age, higher LVE, and greater LAI identified as significant predictors.

摘要

心房颤动(AF)是一种常见的心律失常,它显著增加了心力衰竭(HF)患者,尤其是那些植入了植入式心脏复律除颤器(ICD)的患者的治疗复杂性。AF与不适当的ICD治疗之间的相互作用在优化患者预后方面构成了严峻挑战,因为不适当的电击会导致发病率增加、心理困扰和生活质量下降。我们旨在探讨有ICD植入指征的HF患者中AF的各种临床和人口统计学预测因素。

本研究纳入了122例有ICD植入指征且接受了经胸超声心动图(TE)检查的患者。我们评估了临床和人口统计学因素与AF发生之间的关系,AF在ICD植入前或之后的随访期间被记录。根据我们的研究结果,我们建立了AF的预测因素和风险模型。

在122例植入ICD的HF患者中,52例(42.6%)在ICD植入前或20.5 [6.0;53.0]个月的随访期间经历了AF发作,这是通过ICD的心内膜图记录的。与没有AF的患者相比,有AF的患者年龄更大(<0.001)。此外,他们表现出更高的左心室早期舒张充盈率(LVE)(=0.006)和更大的左心房指数(LAI)(=0.002)。在单变量和多变量逻辑回归分析中,发现这三个因素——年龄、LVE和LAI——与AF独立相关。最终模型包括年龄、LVE和LAI,显示出良好的辨别能力,曲线下面积(AUC)为0.775。在截断值>0.47时,该模型在识别有AF风险的植入ICD的HF患者时,灵敏度为67.3%,特异性为77.2%。

本研究发现,42.6%植入ICD的HF患者经历了AF,年龄较大、LVE较高和LAI较大被确定为重要的预测因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa19/12194515/33c6b0d81a68/jcm-14-04358-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa19/12194515/9290476cd025/jcm-14-04358-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa19/12194515/7ae409db1ad6/jcm-14-04358-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa19/12194515/c81098b719b4/jcm-14-04358-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa19/12194515/33c6b0d81a68/jcm-14-04358-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa19/12194515/9290476cd025/jcm-14-04358-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa19/12194515/7ae409db1ad6/jcm-14-04358-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa19/12194515/c81098b719b4/jcm-14-04358-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa19/12194515/33c6b0d81a68/jcm-14-04358-g004.jpg

相似文献

1
Predictors of Atrial Fibrillation in Heart Failure Patients with Indications for ICD Implantation.有植入式心脏复律除颤器(ICD)植入指征的心力衰竭患者发生心房颤动的预测因素
J Clin Med. 2025 Jun 18;14(12):4358. doi: 10.3390/jcm14124358.
2
A review of the evidence on the effects and costs of implantable cardioverter defibrillator therapy in different patient groups, and modelling of cost-effectiveness and cost-utility for these groups in a UK context.对不同患者群体中植入式心脏复律除颤器治疗的效果和成本相关证据的综述,以及在英国背景下对这些群体的成本效益和成本效用进行建模。
Health Technol Assess. 2006 Aug;10(27):iii-iv, ix-xi, 1-164. doi: 10.3310/hta10270.
3
Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation.静脉注射硫酸镁和索他洛尔预防冠状动脉搭桥术后房颤:系统评价与经济学评估
Health Technol Assess. 2008 Jun;12(28):iii-iv, ix-95. doi: 10.3310/hta12280.
4
Curative catheter ablation in atrial fibrillation and typical atrial flutter: systematic review and economic evaluation.心房颤动和典型心房扑动的根治性导管消融术:系统评价与经济评估
Health Technol Assess. 2008 Nov;12(34):iii-iv, xi-xiii, 1-198. doi: 10.3310/hta12340.
5
Sertindole for schizophrenia.用于治疗精神分裂症的舍吲哚。
Cochrane Database Syst Rev. 2005 Jul 20;2005(3):CD001715. doi: 10.1002/14651858.CD001715.pub2.
6
Implantable Cardioverter-Defibrillator Therapy in Brugada Syndrome: A 30-Year Single-Center Experience.植入式心脏复律除颤器治疗Brugada综合征:30年单中心经验
JACC Clin Electrophysiol. 2025 Jun;11(6):1174-1188. doi: 10.1016/j.jacep.2025.01.013. Epub 2025 Mar 12.
7
Does Augmenting Irradiated Autografts With Free Vascularized Fibula Graft in Patients With Bone Loss From a Malignant Tumor Achieve Union, Function, and Complication Rate Comparably to Patients Without Bone Loss and Augmentation When Reconstructing Intercalary Resections in the Lower Extremity?对于因恶性肿瘤导致骨缺损的患者,在重建下肢节段性切除时,采用带血管游离腓骨移植来增强照射后的自体骨移植,其骨愈合、功能及并发症发生率与无骨缺损且未进行增强的患者相比是否相当?
Clin Orthop Relat Res. 2025 Jun 26. doi: 10.1097/CORR.0000000000003599.
8
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
9
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
10
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状荟萃分析。
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.

本文引用的文献

1
The 2024 European Society of Cardiology Guidelines for Diagnosis and Management of Atrial Fibrillation: A Viewpoint from a Practicing Clinician's Perspective.2024 年欧洲心脏病学会心房颤动诊断和管理指南:临床医生视角。
Thromb Haemost. 2024 Dec;124(12):1087-1094. doi: 10.1055/a-2434-9244. Epub 2024 Oct 7.
2
2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS).2024年欧洲心脏病学会(ESC)心房颤动管理指南,与欧洲心胸外科学会(EACTS)联合制定。
Eur Heart J. 2024 Sep 29;45(36):3314-3414. doi: 10.1093/eurheartj/ehae176.
3
Atrial fibrillation and risk of adverse outcomes in heart failure with reduced, mildly reduced, and preserved ejection fraction: A systematic review and meta-analysis.
心房颤动与射血分数降低、轻度降低和保留的心衰不良结局风险:系统评价和荟萃分析。
J Cardiovasc Electrophysiol. 2024 Apr;35(4):715-726. doi: 10.1111/jce.16209. Epub 2024 Feb 13.
4
Risk prediction of inappropriate implantable cardioverter-defibrillator therapy using machine learning.使用机器学习预测不适当的植入式心脏复律除颤器治疗的风险。
Sci Rep. 2023 Nov 9;13(1):19586. doi: 10.1038/s41598-023-46095-y.
5
A systematic review and meta-analysis of the prevalence, incidence, and predictors of atrial fibrillation in cardiac sarcoidosis.一项系统性回顾和荟萃分析:心脏结节病中心房颤动的患病率、发病率和预测因素。
Int J Cardiol. 2023 Nov 15;391:131285. doi: 10.1016/j.ijcard.2023.131285. Epub 2023 Aug 22.
6
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.2022年美国心脏协会/美国心脏病学会/美国心力衰竭学会心力衰竭管理指南:执行摘要:美国心脏病学会/美国心脏协会临床实践指南联合委员会报告
Circulation. 2022 May 3;145(18):e876-e894. doi: 10.1161/CIR.0000000000001062. Epub 2022 Apr 1.
7
Predictors of atrial fibrillation in patients with ischemic stroke of undetermined etiology.不明原因缺血性脑卒中患者心房颤动的预测因素。
Kardiologiia. 2022 Jan 31;62(1):40-45. doi: 10.18087/cardio.2022.1.n1777.
8
High Incidence of Inappropriate Alarms in Patients with Wearable Cardioverter-Defibrillators: Findings from the Swiss WCD Registry.可穿戴式心脏复律除颤器患者不适当警报的高发生率:来自瑞士可穿戴式心脏复律除颤器注册研究的结果
J Clin Med. 2021 Aug 25;10(17):3811. doi: 10.3390/jcm10173811.
9
Predictors and outcomes of atrial tachyarrhythmia among patients with implantable defibrillators.植入式除颤器患者房性快速性心律失常的预测因素和结果。
Heart Rhythm. 2020 Apr;17(4):553-559. doi: 10.1016/j.hrthm.2019.11.024. Epub 2019 Nov 22.
10
2019 ACC/AHA/ASE Key Data Elements and Definitions for Transthoracic Echocardiography: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Cardiovascular Endpoints Data Standards) and the American Society of Echocardiography.2019年经胸超声心动图关键数据元素及定义:美国心脏病学会/美国心脏协会临床数据标准特别工作组(制定心血管终点数据标准写作委员会)及美国超声心动图学会报告
J Am Coll Cardiol. 2019 Jul 23;74(3):403-469. doi: 10.1016/j.jacc.2019.02.027. Epub 2019 Jun 24.